143 results
Page 4 of 8
8-K
EX-99.1
7ltu1bphuvaddwhnfsk
30 Sep 15
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
jvmai9hy4gb4qds
31 Aug 15
Amicus Therapeutics to Acquire
12:00am
8-K
EX-99.1
87187lk
10 Jun 15
Amicus Therapeutics Strengthens Executive Leadership Team
12:00am
8-K
EX-99.1
7phha
3 Mar 15
Amicus Therapeutics Announces Full-Year 2014
12:00am
8-K
EX-99.2
ptzvl4
12 Jan 15
Other Events
12:00am
8-K
EX-99.1
q2a 2kpf0mg1zf
17 Nov 14
Statistically Significant Improvement in Key Cardiac Parameter in Patients Switched from Enzyme Replacement Therapies to Migalastat
12:00am
8-K
EX-99.1
5ommazuzt69stt09h6
6 Nov 14
Amicus Therapeutics Announces Third Quarter 2014 Financial Results and Corporate Updates
12:00am
8-K
EX-99.2
ym6g0w
20 Aug 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
9up3r80qan5
7 Aug 14
Amicus Therapeutics Announces Second Quarter 2014
12:00am
8-K
EX-99.2
wc8r9
29 Apr 14
Regulation FD Disclosure
12:00am
8-K
EX-99.1
ftzafb2
3 Mar 14
Amicus Therapeutics Appoints Jay A. Barth, MD as Chief Medical Officer and Promotes Bradley L. Campbell to Chief Operating Officer
12:00am
8-K
EX-99.1
ih3qkb73bpf8l rla
3 Mar 14
Amicus Therapeutics Announces Full-Year 2013
12:00am
8-K
EX-99.2
rydye5oy3zy
13 Jan 14
Other Events
12:00am
8-K
EX-99.1
q2nxu f9b
30 Dec 13
Amicus Therapeutics Completes Debt
12:00am
8-K
EX-99.1
qmg0lckzk1 d5kyn7n
21 Nov 13
Callidus Biopharma Acquisition Adds Next-Generation Pompe ERT and Enzyme Technology Platform
12:00am
8-K
EX-99.1
z2hemupjlxh5w5wlc
20 Nov 13
Amicus Therapeutics and GSK Announce Revised Fabry Agreement
12:00am
8-K
EX-99.1
68hp4sanq qi
10 Sep 13
Other Events
12:00am
8-K
EX-99.1
6hdg6koiid6y287oh0o
7 Aug 13
Amicus Therapeutics Announces Second Quarter
12:00am